Paul TheisenPatient Acquisition
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Matt TurnerPatient Affordability
Stacey GandlerBrand Nourishment
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
Joey CohenMedication Adherence
Suma Ramadas, PhDMedical Affairs
Apricus Expects to Report Top-Line Phase 2b Data in Q1 2016 SAN DIEGO, Dec. ...
Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email
